Signal peptidases are serine endoproteinases responsible for the prote
olytic removal of N-terminal amino acid signal sequences from pre-secr
etory proteins in all cellular lifeforms including bacteria. The demon
strated essentiality of the enzymatic activity and the ubiquitous occu
rrence in bacteria, coupled with the significant molecular differences
between bacterial signal peptidases and those of eukaryotes, define t
hese enzymes as potential molecular targets for the development of nov
el antibacterial agents. Few compounds are known to inhibit bacterial
signal peptidases and the most significant advance in SPase inhibition
has been the discovery of penem systems as time dependent irreversibl
e inhibitors. They are thought to act via acylation of the active site
serine. SPases are only acylated by the 5 (S) under bar penem stereoc
hemistry, a stereochemical preference mirrored in other azetidinone co
ntaining inhibitors. The implications of this is that the active site
serine of SPases approach their substrate from the opposite side of th
e peptidic backbone to that of all other serine protease families whos
e structures are known. The activity of penems is significantly enhanc
ed by the incorporation of a C6 hydroxyethyl substituent, thought to b
ind into the S-1 pocket of the enzyme. Penem inhibition of SPases has
been demonstrated in vitro, in isolated enzyme assays, and in vivo in
pulse-chase assays.